Thursday, 27 January 2022

Australia's most trusted
source of pharma news

Thursday, 27 January 2022

Zimmerman's access revolution

Posted 25 November 2021 PM

A brand new centre to be established inside the federal Department of Health with the specific aim of fast-tracking access to new medicines and medical technologies is just one of a sweeping list of reforms recommended in the newly released Zimmerman inquiry report which was tabled in federal parliament today.

The new Centre for Precision Medicine and Rare Diseases would ensure that HTA processes and the government's research agenda aligns with the outcome of "timely access to new drugs and novel medical technologies". It would also operate a comprehensive "horizon scanning" unit for new therapies.

To see the whole article, please login

Email this article to a friend

Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.


Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.


Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).


You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.


You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.